Leonie Vangansbeke

Leonie Vangansbeke is a seasoned professional in quality management and regulatory compliance with extensive experience in the biotech and medical devices sectors. Currently serving as the Head of Quality at Confo Therapeutics since March 2022, Leonie has played a key role in establishing a strong quality infrastructure and contributing to the company's IPO. As the Founder and Trainer at Aurélia since May 2016, expertise includes root cause analysis, risk management, and quality awareness training. Previous positions include Head of Quality at Precigen ActoBio, where responsibilities encompassed ensuring compliance within quality management systems, and consulting roles at notable companies such as Pfizer and Johnson & Johnson, focusing on quality risk management and supplier quality assurance. Leonie has a comprehensive background in regulatory compliance and quality assurance across various industries, demonstrating a commitment to enhancing quality and compliance standards.